KPIs & Operating Metrics(New)
Growth Metrics

Bristol Myers Squibb (BMY) Assets Growth (5y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -5.11%
Dec 31, 2025 -5.34%
Sep 30, 2025 -5.05%
Jun 30, 2025 -5.86%
Mar 31, 2025 -6.49%
Dec 31, 2024 -6.55%
Sep 30, 2024 10.28%
Jun 30, 2024 11.40%
Mar 31, 2024 23.24%
Dec 31, 2023 22.15%
Sep 30, 2023 22.02%
Jun 30, 2023 23.42%
Mar 31, 2023 23.30%
Dec 31, 2022 23.61%
Sep 30, 2022 23.65%
Jun 30, 2022 24.61%
Mar 31, 2022 25.62%
Dec 31, 2021 26.53%
Sep 30, 2021 26.88%
Jun 30, 2021 27.54%
Mar 31, 2021 28.66%
Dec 31, 2020 30.13%
Sep 30, 2020 31.62%
Jun 30, 2020 32.00%
Mar 31, 2020 30.95%
Dec 31, 2019 30.95%
Sep 30, 2019 11.42%
Jun 30, 2019 10.49%
Mar 31, 2019 0.83%
Dec 31, 2018 -1.94%
Sep 30, 2018 -1.73%
Jun 30, 2018 -2.08%
Mar 31, 2018 -1.65%
Dec 31, 2017 -1.34%
Sep 30, 2017 -1.17%
Jun 30, 2017 1.08%
Mar 31, 2017 0.32%
Dec 31, 2016 0.44%
Sep 30, 2016 1.05%
Jun 30, 2016 0.62%
Mar 31, 2016 0.67%
Dec 31, 2015 0.43%
Dec 31, 2014 1.71%
Sep 30, 2014 1.57%
Jun 30, 2014 2.36%